NTRK1 and diabetes mellitus: Further we showed that diabetes- or glucose-induced ErbB3, and Erbb4 transactivation could be attenuated by Ang-(1–7) treatment thereby implying that Ang-(1–7) is a pan-inhibitor of the ErbB family of receptor tyrosine kinases.